-
srdr.ahrq.gov/projects/1596/studies/192259
January 01, 2005 - Deterioration over time in effect of Motivational Interviewing in reducing drug consumption and related risk … Deterioration over time in effect of Motivational Interviewing in reducing drug consumption and related risk
-
srdr.ahrq.gov/projects/1604/studies/198051
January 01, 1993 - Study Preview
Study Title and Description
Identifying children at high risk … Post/View
Title Data
Title
Identifying children at high risk
-
srdr.ahrq.gov/projects/1626/studies/193190
January 01, 2017 - Title and Description
Using a Self-Reported Global Health Measure to Identify Patients at High Risk … Data
Title
Using a Self-Reported Global Health Measure to Identify Patients at High Risk
-
srdr.ahrq.gov/projects/1603/studies/197995
January 01, 1999 - Study Title and Description
Safety of metronidazole during pregnancy: a cohort study of risk … Title Data
Title
Safety of metronidazole during pregnancy: a cohort study of risk
-
srdr.ahrq.gov/projects/1603/studies/197968
January 01, 1999 - Prevalence of bacterial vaginosis and correlation of clinical to Gram stain diagnostic criteria in low risk … Prevalence of bacterial vaginosis and correlation of clinical to Gram stain diagnostic criteria in low risk
-
srdr.ahrq.gov/projects/1312/studies/133117
January 01, 2012 - 1
Is dietary intake of flavan-3ols associated with cardiovascular health outcomes and risk … Baseline Health Status
Adults at an increased risk … Comments ( 0 ) |
Post/View
Adults at an increased risk … Comments ( 0 ) |
Post/View
Adults at an increased risk … Comments ( 0 ) |
Post/View
Adults at an increased risk
-
srdr.ahrq.gov/projects/1312/studies/133271
January 01, 2011 - 1
Is dietary intake of flavan-3ols associated with cardiovascular health outcomes and risk … Baseline Health Status
Adults at an increased risk … Comments ( 0 ) |
Post/View
Adults at an increased risk … Comments ( 0 ) |
Post/View
Adults at an increased risk … Comments ( 0 ) |
Post/View
Adults at an increased risk
-
srdr.ahrq.gov/projects/1312/studies/147773
January 01, 2017 - 1
Is dietary intake of flavan-3ols associated with cardiovascular health outcomes and risk … Baseline Health Status
Adults at an increased risk … Comments ( 0 ) |
Post/View
Adults at an increased risk
-
srdr.ahrq.gov/projects/1312/studies/133178
January 01, 2008 - 1
Is dietary intake of flavan-3ols associated with cardiovascular health outcomes and risk … Country
Clinical Nutrition & Risk Factor Modification Center, St Michael's Hospital … Baseline Health Status
Adults at an increased risk … Comments ( 0 ) |
Post/View
Adults at an increased risk
-
srdr.ahrq.gov/projects/1565/studies/188957
January 01, 2018 - Risk Difference (RD)
0.49
Mean
1.2 … Risk Difference (RD)
Mean
Adj. 95% CI low
SD … Risk Difference (RD)
0.16
Mean
Adj. 95% CI low … Risk Difference (RD)
Mean
Adj. 95% CI low
SD … Risk Difference (RD)
1.34
Mean
Adj. 95% CI low
-
srdr.ahrq.gov/projects/1603/studies/197998
January 01, 1998 - Study Preview
Study Title and Description
Prenatal exposure to metronidazole and risk … Post/View
Title Data
Title
Prenatal exposure to metronidazole and risk
-
srdr.ahrq.gov/projects/1604/studies/198054
January 01, 2003 - Study Preview
Study Title and Description
Childhood cardiovascular risk … |
Post/View
Title Data
Title
Childhood cardiovascular risk
-
srdr.ahrq.gov/projects/1596/studies/192264
January 01, 2004 - single-session motivational interviewing in reducing drug consumption and perceptions of drug-related risk … single-session motivational interviewing in reducing drug consumption and perceptions of drug-related risk
-
srdr.ahrq.gov/projects/1671/studies/196089
January 01, 1995 - considered for opioid therapy for acute treatment, what is the accuracy of instruments for predicting risk … considered for opioid therapy for acute treatment, what is the effectiveness of instruments for predicting risk … migraine being considered for opioid therapy for acute treatment, what is the effect of the following risk
-
srdr.ahrq.gov/projects/1671/studies/196093
January 01, 1995 - considered for opioid therapy for acute treatment, what is the accuracy of instruments for predicting risk … considered for opioid therapy for acute treatment, what is the effectiveness of instruments for predicting risk … migraine being considered for opioid therapy for acute treatment, what is the effect of the following risk
-
srdr.ahrq.gov/projects/1671/studies/196088
January 01, 2008 - considered for opioid therapy for acute treatment, what is the accuracy of instruments for predicting risk … considered for opioid therapy for acute treatment, what is the effectiveness of instruments for predicting risk … migraine being considered for opioid therapy for acute treatment, what is the effect of the following risk
-
srdr.ahrq.gov/projects/1671/studies/196090
considered for opioid therapy for acute treatment, what is the accuracy of instruments for predicting risk … considered for opioid therapy for acute treatment, what is the effectiveness of instruments for predicting risk … migraine being considered for opioid therapy for acute treatment, what is the effect of the following risk
-
srdr.ahrq.gov/projects/1671/studies/196091
considered for opioid therapy for acute treatment, what is the accuracy of instruments for predicting risk … considered for opioid therapy for acute treatment, what is the effectiveness of instruments for predicting risk … migraine being considered for opioid therapy for acute treatment, what is the effect of the following risk
-
srdr.ahrq.gov/projects/1671/studies/196096
January 01, 2011 - considered for opioid therapy for acute treatment, what is the accuracy of instruments for predicting risk … considered for opioid therapy for acute treatment, what is the effectiveness of instruments for predicting risk … migraine being considered for opioid therapy for acute treatment, what is the effect of the following risk
-
srdr.ahrq.gov/projects/1324/studies/148569
January 01, 2008 - Preview
Study Title and Description
Therapeutic management, delivery, and postpartum risk … /View
Title Data
Title
Therapeutic management, delivery, and postpartum risk … Therapeutic Management, Delivery, and Postpartum Risk Assessment and Screening in Gestational Diabetes